FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2143116209> ?p ?o ?g. }

• W2143116209 abstract "ABSTRACT Epsilon toxin (ETX), a pore-forming toxin produced by type B and D strains of Clostridium perfringens , mediates severe enterotoxemia in livestock and possibly plays a role in human disease. During enterotoxemia, the nearly inactive ETX prototoxin is produced in the intestines but then must be activated by proteolytic processing. The current study sought to examine ETX prototoxin processing and activation ex vivo using the intestinal contents of a goat, a natural host species for ETX-mediated disease. First, this study showed that the prototoxin has a KEIS N-terminal sequence with a molecular mass of 33,054 Da. When the activation of ETX prototoxin ex vivo by goat small intestinal contents was assessed by SDS-PAGE, the prototoxin was processed in a stepwise fashion into an ~27-kDa band or higher-molecular-mass material that could be toxin oligomers. Purified ETX corresponding to the ~27-kDa band was cytotoxic. When it was biochemically characterized by mass spectrometry, the copresence of three ETX species, each with different C-terminal residues, was identified in the purified ~27-kDa ETX preparation. Cytotoxicity of each of the three ETX species was then demonstrated using recombinant DNA approaches. Serine protease inhibitors blocked the initial proteotoxin processing, while carboxypeptidase inhibitors blocked further processing events. Taken together, this study provides important new insights indicating that, in the intestinal lumen, serine protease (including trypsin and possibly chymotrypsin) initiates the processing of the prototoxin but other proteases, including carboxypeptidases, then process the prototoxin into multiple active and stable species. IMPORTANCE Processing and activation by intestinal proteases is a prerequisite for ETX-induced toxicity. Previous studies had characterized the activation of ETX using only arbitrarily chosen amounts of purified trypsin and/or chymotrypsin. Therefore, the current study examined ETX activation ex vivo by natural host intestinal contents. These analyses demonstrated that (i) ETX processing in host intestinal contents occurs in an ordered, stepwise fashion, (ii) processing of prototoxin by host intestinal contents results in higher-molecular-mass material and 3 distinct ~27-kDa ETX species, and (iii) serine proteases, such as trypsin, chymotrypsin, and other proteases, including carboxypeptidases, play a role in the activation of ETX by intestinal contents. These studies provide new insights into the activation and processing of ETX and demonstrate that this process is more complicated than previously appreciated." @default.
• W2143116209 created "2016-06-24" @default.
• W2143116209 creator A5047683626 @default.
• W2143116209 creator A5063383376 @default.
• W2143116209 creator A5068160025 @default.
• W2143116209 creator A5089450547 @default.
• W2143116209 date "2014-10-31" @default.
• W2143116209 modified "2023-09-24" @default.
• W2143116209 title "Proteolytic Processing and Activation of Clostridium perfringens Epsilon Toxin by Caprine Small Intestinal Contents" @default.
• W2143116209 cites W1483281977 @default.
• W2143116209 cites W1543571891 @default.
• W2143116209 cites W1561024000 @default.
• W2143116209 cites W1889648423 @default.
• W2143116209 cites W1964630348 @default.
• W2143116209 cites W1967842893 @default.
• W2143116209 cites W1969209049 @default.
• W2143116209 cites W1972731882 @default.
• W2143116209 cites W1984158664 @default.
• W2143116209 cites W1984561439 @default.
• W2143116209 cites W1992070708 @default.
• W2143116209 cites W1994994353 @default.
• W2143116209 cites W2031704987 @default.
• W2143116209 cites W2032896244 @default.
• W2143116209 cites W2035067997 @default.
• W2143116209 cites W2051365194 @default.
• W2143116209 cites W2066832585 @default.
• W2143116209 cites W2080848411 @default.
• W2143116209 cites W2099792326 @default.
• W2143116209 cites W2110078066 @default.
• W2143116209 cites W2133157009 @default.
• W2143116209 cites W2142697899 @default.
• W2143116209 cites W2162844206 @default.
• W2143116209 cites W2171947762 @default.
• W2143116209 cites W2397071770 @default.
• W2143116209 doi "https://doi.org/10.1128/mbio.01994-14" @default.
• W2143116209 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4212841" @default.
• W2143116209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25336460" @default.
• W2143116209 hasPublicationYear "2014" @default.
• W2143116209 type Work @default.
• W2143116209 sameAs 2143116209 @default.
• W2143116209 citedByCount "23" @default.
• W2143116209 countsByYear W21431162092015 @default.
• W2143116209 countsByYear W21431162092016 @default.
• W2143116209 countsByYear W21431162092018 @default.
• W2143116209 countsByYear W21431162092019 @default.
• W2143116209 countsByYear W21431162092020 @default.
• W2143116209 countsByYear W21431162092021 @default.
• W2143116209 countsByYear W21431162092023 @default.
• W2143116209 crossrefType "journal-article" @default.
• W2143116209 hasAuthorship W2143116209A5047683626 @default.
• W2143116209 hasAuthorship W2143116209A5063383376 @default.
• W2143116209 hasAuthorship W2143116209A5068160025 @default.
• W2143116209 hasAuthorship W2143116209A5089450547 @default.
• W2143116209 hasBestOaLocation W21431162091 @default.
• W2143116209 hasConcept C108477463 @default.
• W2143116209 hasConcept C109316439 @default.
• W2143116209 hasConcept C153911025 @default.
• W2143116209 hasConcept C181199279 @default.
• W2143116209 hasConcept C182220744 @default.
• W2143116209 hasConcept C185592680 @default.
• W2143116209 hasConcept C202751555 @default.
• W2143116209 hasConcept C2776414213 @default.
• W2143116209 hasConcept C2776714187 @default.
• W2143116209 hasConcept C2777367657 @default.
• W2143116209 hasConcept C2777807008 @default.
• W2143116209 hasConcept C2779116991 @default.
• W2143116209 hasConcept C2780340462 @default.
• W2143116209 hasConcept C523546767 @default.
• W2143116209 hasConcept C54355233 @default.
• W2143116209 hasConcept C55493867 @default.
• W2143116209 hasConcept C58121356 @default.
• W2143116209 hasConcept C86803240 @default.
• W2143116209 hasConcept C89423630 @default.
• W2143116209 hasConceptScore W2143116209C108477463 @default.
• W2143116209 hasConceptScore W2143116209C109316439 @default.
• W2143116209 hasConceptScore W2143116209C153911025 @default.
• W2143116209 hasConceptScore W2143116209C181199279 @default.
• W2143116209 hasConceptScore W2143116209C182220744 @default.
• W2143116209 hasConceptScore W2143116209C185592680 @default.
• W2143116209 hasConceptScore W2143116209C202751555 @default.
• W2143116209 hasConceptScore W2143116209C2776414213 @default.
• W2143116209 hasConceptScore W2143116209C2776714187 @default.
• W2143116209 hasConceptScore W2143116209C2777367657 @default.
• W2143116209 hasConceptScore W2143116209C2777807008 @default.
• W2143116209 hasConceptScore W2143116209C2779116991 @default.
• W2143116209 hasConceptScore W2143116209C2780340462 @default.
• W2143116209 hasConceptScore W2143116209C523546767 @default.
• W2143116209 hasConceptScore W2143116209C54355233 @default.
• W2143116209 hasConceptScore W2143116209C55493867 @default.
• W2143116209 hasConceptScore W2143116209C58121356 @default.
• W2143116209 hasConceptScore W2143116209C86803240 @default.
• W2143116209 hasConceptScore W2143116209C89423630 @default.
• W2143116209 hasIssue "5" @default.
• W2143116209 hasLocation W21431162091 @default.
• W2143116209 hasLocation W21431162092 @default.
• W2143116209 hasLocation W21431162093 @default.
• W2143116209 hasLocation W21431162094 @default.
• W2143116209 hasLocation W21431162095 @default.
• W2143116209 hasLocation W21431162096 @default.
• W2143116209 hasLocation W21431162097 @default.

• next